Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 11.50
-0.50 (-4.17%)
Jul 6, 2026, 4:28 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 14.38 million as of July 6, 2026. Its market cap has increased by 96.12% in one year.
Market Cap
14.38M
Enterprise Value
14.51M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.50
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 14.38M, a decrease of -47.30%. That is a compound annual growth rate of -7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 14.38M | -9.64% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 29.10M |
| SkinBioTherapeutics | 27.21M |
| Arecor Therapeutics | 23.98M |
| ImmuPharma | 21.68M |
| IXICO | 17.99M |
| Aptamer Group | 16.41M |
| Palatin Technologies | 14.43M |
| Genflow Biosciences | 11.61M |